Chronic Kidney DiseaseVETCKDNCT07793591
Veteran Centered Meal Intervention in Chronic Kidney Disease
A study testing Medically tailored meals (MTMs) in people with Chronic Kidney Disease, run by VA Office of Research and Development at 1 site in United States.
Trial summary
This study will study if medically tailored meals can improve health and well-being among Veterans with kidney disease. Participants will be randomly assigned to receive either medically tailored meals or usual care (wait-list control) for 3 months, followed by follow-up/crossover period. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Chronic Kidney Disease
- What is being tested?
- Medically tailored meals (MTMs)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Oct 2027to 31 Aug 2030
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Veteran enrolled in the Veterans Health Administration
- Stage 3b or stage 4 Chronic Kidney Disease (CKD) ((estimated glomerular filtration rate (eGFR) 15-44 milliliter (mL)/minute/1.73 square meter (m²))
- Systolic blood pressure 140-160 mmHg (millimeters of mercury); with a ± 5 mmHg tolerance range
- Body mass index (BMI) between 18.5 and 40.0 kilogram (kg)/square meter (m²)
- Able and willing to provide informed consent
- Able and willing to participate in study visits and study procedures
- Able to receive medically tailored meal deliveries within the study service area
Who cannot join
- Inability to communicate in English or severe hearing impairment either, preventing study participation
- Participation in a medically tailored meal program within the previous 6 months
- Diagnosis of heart failure
- Major active gastrointestinal disorder that would interfere with participation or nutritional management
- Active cancer treatment (chemotherapy) or anticipated treatment within the next 12 months
- Pregnancy
Show all 11Show fewer
- Current homelessness preventing meal delivery
- Active substance use disorder not in remission
- Active psychosis or another condition that would impair participation
- Terminal illness or life expectancy less than 12 months
- Any other medical, psychiatric, or social condition that, in the opinion of the investigators, would make participation unsafe or interfere with completion of the study
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, Colorado, 80045-7211
Luis M Perez, PhD RD, (720) 467-0757, luis.perez2@va.gov
Maryam I Nuriyeva, MPH, (720) 857-2712, Maryam.Nuriyeva@va.gov
About this study
Official title: A Veteran-Centered Medically Tailored Meal Intervention to Improve Clinical and Patient Reported Outcomes in Chronic Kidney Disease (VETCKD)
This study will study if medically tailored meals can improve health and well-being among Veterans with kidney disease. Participants will be randomly assigned to receive either medically tailored meals or usual care (wait-list control) for 3 months, followed by follow-up/crossover period. The study will evaluate blood pressure, kidney health, diet, quality of life, and other health outcomes, as well as the feasibility and acceptability of providing medically tailored meals to Veterans with kidney disease.
Read the detailed description
This pilot randomized clinical trial will evaluate the feasibility, acceptability, and preliminary effects of medically tailored meals among Veterans with chronic kidney disease. Approximately 100 Veterans with stage 3b or 4 chronic kidney disease and elevated systolic blood pressure will be enrolled and randomized 1:1 to receive medically tailored meals or usual care during an initial 3-month intervention period. Participants initially assigned to usual care will subsequently receive medically tailored meals during a 3-month crossover period. All participants will be followed for 6 months.
The medically tailored meal intervention will provide prepared meals designed to support dietary recommendations for chronic kidney disease and cardiovascular health. The study will assess intervention feasibility and acceptability, including recruitment, adherence, retention, completion of study assessments, and participant experiences with the meals.
Clinical outcomes will include systolic blood pressure, kidney function and injury measures, cardiometabolic laboratory markers, and vascular function. Dietary intake and diet quality will be assessed using 24-hour dietary recalls. Patient-reported and behavioral outcomes will include kidney disease-related quality of life, general health and well-being, treatment burden, and measures related to dietary behavior and self-management. Healthcare utilization and medication use will also be evaluated. Assessments will generally occur at baseline, 3 months, and 6 months.
- Conditions
- Chronic Kidney Disease
- Being tested
- Medically tailored meals (MTMs)
- Keywords
- medically tailored meals, chronic kidney disease, hypertension, nutrition, diet, Veterans
- Medical subject headings
- Renal Insufficiency, Chronic, Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Medically tailored meals (MTMs)Other
Also called MTM
Medically tailored meals are prepared to support dietary recommendations for chronic kidney disease and cardiovascular health while considering individual dietary needs and preferences. The intervention also included nutrition education and study-related dietary support.
| Study group | Role | What they receive |
|---|---|---|
| Medically tailored meals | Experimental | Participants randomized to this arm will receive medically tailored meals for 3 months in addition to usual clinical care. Meals will be designed to support dietary recommendations for chronic kidney disease, kidney and cardiovascular health. Participants will also receive nutrition education and study-related dietary support. Receives: Other: Medically tailored meals (MTMs) |
| Wait-list control | Other | Participants randomized to this arm will continue usual clinical care without study-provided medically tailored meals during the initial 3-month randomized period. After completing the 3-month assessment, participants will cross over to receive the medically tailored meals intervention for 3 months. Receives: Other: Medically tailored meals (MTMs) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Systolic blood pressure (SBP)
Change in systolic blood pressure (SBP), measured in mmHg, from baseline to the 3-month assessment.
Measured: 3 months
Secondary outcomes (2)
Urine albumin-to-creatinine ratio (UACR)
Change in urine albumin-to-creatinine ratio (UACR; milligrams/gram) from baseline to 3 months, measured using urine laboratory testing through the VA clinical laboratory.
Measured: 3 months
Estimated glomerular filtration rate (eGFR)
Change in estimated glomerular filtration rate (eGFR; milliliter/minute/1.73^square meter) from baseline to 3 months, based on serum creatinine OR cystatin C, measured through the VA clinical laboratory.
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Aug 2026
- Study start1 Oct 2027 (estimated)
- Primary completion31 May 2030 (estimated)
- Study completion31 Aug 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Chronic Kidney DiseaseStudies of the same condition, open and under way.
- More trials run by VA Office of Research and DevelopmentThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants will be randomized 1:1 to the medically tailored meal intervention or wait-list control group and followed in parallel.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- VA Office of Research and Development
- Sponsor type
- US federal agency
- Responsible party
- Sponsor
- Investigators
- Luis M Perez, PhD RD, Principal investigator, Rocky Mountain Regional VA Medical Center, Aurora, CO
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07793591
- Sponsor's protocol ID
- NEPH-008-26S
- Other IDs
- 1IK2RD002463
- Acronym
- VETCKD
- Status last verified
- Aug 2026
- First submitted
- 18 Aug 2026
- Last updated
- 3 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Perez LM, Ujano-De Motta L, Johnson-Koenke R, Jani A, Ikizler TA, Raghavan S, Leonard C, Jones CD. A Qualitative Study to Investigate the Nutrition Perspectives and Experiences of Veterans with CKD. Clin J Am Soc Nephrol. 2025 Nov 1;20(11):1503-1515. doi: 10.2215/CJN.0000000800. Epub 2025 Aug 8.
PubMed 40779332Perez L, Gendelman S, Kendrick J. Home-Delivered Medically Tailored Meal Engagement Among Hemodialysis Patients and Providers. J Ren Nutr. 2024 Jan;34(1):40-46. doi: 10.1053/j.jrn.2023.08.011. Epub 2023 Aug 26.
PubMed 37640277Perez LM, Biruete A, Wilund KR. Home-delivered meals as an adjuvant to improve volume overload and clinical outcomes in hemodialysis. Clin Kidney J. 2022 Apr 19;15(10):1829-1837. doi: 10.1093/ckj/sfac102. eCollection 2022 Oct.
PubMed 36158146
Study at a glance
From the registry record, last updated by the sponsor on 3 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Veteran-Centered Medically Tailored Meal Intervention to Improve Clinical and Patient Reported Outcomes in Chronic Kidney Disease (VETCKD)
- ClinicalTrials.gov ID
- NCT07793591
- Acronym / sponsor ID
- VETCKD / NEPH-008-26S
- Conditions
- Chronic Kidney Disease
- Keywords
- medically tailored meals, chronic kidney disease, hypertension, nutrition, diet, Veterans
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- VA Office of Research and DevelopmentUS federal agency
- Study start
- 1 Oct 2027 (estimated)
- Primary completion
- 31 May 2030 (estimated)
- Study completion
- 31 Aug 2030 (estimated)
- First posted
- 28 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will study if medically tailored meals can improve health and well-being among Veterans with kidney disease. Participants will be randomly assigned to receive either medically tailored meals or usual care (wait-list control) for 3 months, followed by follow-up/crossover period. The study will evaluate blood pressure, kidney health, diet, quality of life, and other health outcomes, as well as the feasibility and acceptability of providing medically tailored meals to Veterans with kidney disease.
Detailed description
This pilot randomized clinical trial will evaluate the feasibility, acceptability, and preliminary effects of medically tailored meals among Veterans with chronic kidney disease. Approximately 100 Veterans with stage 3b or 4 chronic kidney disease and elevated systolic blood pressure will be enrolled and randomized 1:1 to receive medically tailored meals or usual care during an initial 3-month intervention period. Participants initially assigned to usual care will subsequently receive medically tailored meals during a 3-month crossover period. All participants will be followed for 6 months.
The medically tailored meal intervention will provide prepared meals designed to support dietary recommendations for chronic kidney disease and cardiovascular health. The study will assess intervention feasibility and acceptability, including recruitment, adherence, retention, completion of study assessments, and participant experiences with the meals.
Clinical outcomes will include systolic blood pressure, kidney function and injury measures, cardiometabolic laboratory markers, and vascular function. Dietary intake and diet quality will be assessed using 24-hour dietary recalls. Patient-reported and behavioral outcomes will include kidney disease-related quality of life, general health and well-being, treatment burden, and measures related to dietary behavior and self-management. Healthcare utilization and medication use will also be evaluated. Assessments will generally occur at baseline, 3 months, and 6 months.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Participants will be randomized 1:1 to the medically tailored meal intervention or wait-list control group and followed in parallel.
| Arm | Type | Receives |
|---|---|---|
| Medically tailored meals | Experimental | Other: Medically tailored meals (MTMs)Participants randomized to this arm will receive medically tailored meals for 3 months in addition to usual clinical care. Meals will be designed to support dietary recommendations for chronic kidney disease, kidney and cardiovascular health. Participants will also receive nutrition education and study-related dietary support. |
| Wait-list control | Other | Other: Medically tailored meals (MTMs)Participants randomized to this arm will continue usual clinical care without study-provided medically tailored meals during the initial 3-month randomized period. After completing the 3-month assessment, participants will cross over to receive the medically tailored meals intervention for 3 months. |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Veteran enrolled in the Veterans Health Administration
- Stage 3b or stage 4 Chronic Kidney Disease (CKD) ((estimated glomerular filtration rate (eGFR) 15-44 milliliter (mL)/minute/1.73 square meter (m²))
- Systolic blood pressure 140-160 mmHg (millimeters of mercury); with a ± 5 mmHg tolerance range
- Body mass index (BMI) between 18.5 and 40.0 kilogram (kg)/square meter (m²)
- Able and willing to provide informed consent
Key exclusion criteria (11 listed)
- Inability to communicate in English or severe hearing impairment either, preventing study participation
- Participation in a medically tailored meal program within the previous 6 months
- Diagnosis of heart failure
- Major active gastrointestinal disorder that would interfere with participation or nutritional management
- Active cancer treatment (chemotherapy) or anticipated treatment within the next 12 months
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Medically tailored meals (MTMs)Also: MTMMedically tailored meals are prepared to support dietary recommendations for chronic kidney disease and cardiovascular health while considering individual dietary needs and preferences. The intervention also included nutrition education and study-related dietary support. | Other | Medically tailored meals, Wait-list control |
Primary outcome
Systolic blood pressure (SBP)
Time frame: 3 months
Change in systolic blood pressure (SBP), measured in mmHg, from baseline to the 3-month assessment.
2 secondary outcomes
Urine albumin-to-creatinine ratio (UACR)
Time frame: 3 months
Estimated glomerular filtration rate (eGFR)
Time frame: 3 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Sep 2026.
- Background: PubMed 40779332Perez LM, Ujano-De Motta L, Johnson-Koenke R, Jani A, Ikizler TA, Raghavan S, Leonard C, Jones CD. A Qualitative Study to Investigate the Nutrition Perspectives and Experiences of Veterans with CKD. Clin J Am Soc Nephrol. 2025 Nov 1;20(11):1503-1515. doi: 10.2215/CJN.0000000800. Epub 2025 Aug 8.
- Background: PubMed 37640277Perez L, Gendelman S, Kendrick J. Home-Delivered Medically Tailored Meal Engagement Among Hemodialysis Patients and Providers. J Ren Nutr. 2024 Jan;34(1):40-46. doi: 10.1053/j.jrn.2023.08.011. Epub 2023 Aug 26.
- Background: PubMed 36158146Perez LM, Biruete A, Wilund KR. Home-delivered meals as an adjuvant to improve volume overload and clinical outcomes in hemodialysis. Clin Kidney J. 2022 Apr 19;15(10):1829-1837. doi: 10.1093/ckj/sfac102. eCollection 2022 Oct.
- Individual participant dataSharing planned: No
Related trials for Chronic Kidney Disease
RecruitingObservational study
Urinary Biomarker-Based Diagnostic and Monitoring System for Chronic Kidney Disease and Real-World Effectiveness of SGLT2 Inhibitors
Chronic Kidney Disease
Active, not recruitingObservational study
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Practice
Chronic Kidney Disease, Type 2 Diabetes Mellitus
RecruitingObservational study
Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the Assessment of Patients Awaiting Kidney Transplantation
Cardiovascular Diseases, Kidney Transplant; Complications
Not yet recruiting
Manual Acupuncture for Intradialytic Nausea and Vomiting in Patients Undergoing Hemodialysis
Intradialytic Nausea and Vomiting, Chronic Kidney Disease
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
Chronic Kidney Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Luis M Perez, PhD RD principal investigator
Rocky Mountain Regional VA Medical Center, Aurora, CO
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Medically tailored meals (MTMs) in people with Chronic Kidney Disease, run by VA Office of Research and Development at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 3 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Luis M Perez, PhD RD ((720) 467-0757, luis.perez2@va.gov), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Systolic blood pressure (SBP) (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07793591, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2026.